Swing Therapeutics
Swing Therapeutics develops Stanza, an FDA-cleared prescription digital therapeutic that delivers Acceptance and Commitment Therapy via smartphone for adults with fibromyalgia, complemented by its Swing Care virtual specialty clinic operating in eight U.S. states.
- Company typePrivate
- Founded2019
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2C
- OfferingSoftware
What Swing Therapeutics does
Swing Therapeutics, Inc. is a San Francisco-based digital therapeutics company founded in 2019 that develops evidence-based, software-delivered treatments for chronic conditions, with a primary focus on fibromyalgia. Its flagship product, Stanza, is an FDA-cleared prescription digital therapeutic that delivers Acceptance and Commitment Therapy (ACT) through a 12-week, 15-20-minute daily smartphone program available on iOS and Android. The underlying technology is a content-driven behavioral therapy engine backed by an exclusive license from the University of Manitoba, with 17 software releases and 7 clinical trials supporting iterative product refinement; the Phase 3 PROSPER-FM trial (275 participants) published in The Lancet represents the largest randomized controlled trial ever conducted on a fibromyalgia device treatment.
The company operates a dual business model. Stanza is distributed as a prescription-only digital therapeutic through three channels: the iOS App Store and Google Play Store (where it can be downloaded with a valid prescription), clinical partner practices (UPMC in Pennsylvania, Southwest Medical in Nevada), and Swing Care — Swing's own virtual specialty clinic offering comprehensive fibromyalgia treatment including medication management, lifestyle coaching, and Stanza. Swing Care currently operates in eight states (Illinois, Tennessee, Texas, Pennsylvania, Michigan, Missouri, Nevada, Ohio). Reimbursement is enabled through payer coverage decisions, with Highmark Health providing commercial coverage for members across Pennsylvania, West Virginia, Delaware, and New York. Revenue is generated through insurance reimbursement for prescription fills and through professional services fees from Swing Care, though specific pricing and revenue figures are not publicly disclosed.
Swing Therapeutics firmographics
Firmographics- Name
- Swing Therapeutics
- Legal name
- Swing Therapeutics, Inc.
- Website
- https://swingtherapeutics.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Swing Therapeutics develops Stanza, an FDA-cleared prescription digital therapeutic that delivers Acceptance and Commitment Therapy via smartphone for adults with fibromyalgia, complemented by its Swing Care virtual specialty clinic operating in eight U.S. states.
- Ownership category
- akta.pro rank
Swing Therapeutics industry classification
Industry- Product category
- Digital Therapeutics
- NAICS
- Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
- akta.pro secondary industries
- Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)
Keywords
Where Swing Therapeutics is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Swing Therapeutics business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Prescription Digital Therapeutic Sales: Stanza is prescribed by healthcare providers and reimbursed through insurance. The company has secured coverage decisions from payers like Highmark Health for their commercial members.
- Swing Care Virtual Clinic Services: Swing Care, a specialty virtual clinic for fibromyalgia treatment, offers comprehensive care including medication management and non-pharmacological therapies, with Stanza as a treatment option. Services are available in Illinois, Tennessee, Texas, and Pennsylvania.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Not disclosed | Prescription digital therapeutic covered by insurance |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Swing Therapeutics product offering
Product offeringCore offering
Swing Therapeutics develops and sells Stanza, an FDA-cleared prescription digital therapeutic that delivers Acceptance and Commitment Therapy (ACT) through a smartphone application for adult patients with fibromyalgia. The 12-week, 15-minute-per-day self-guided program includes lessons, mindfulness exercises, journaling, and symptom tracking, and is complemented by Swing Care, the company's own virtual specialty clinic offering comprehensive fibromyalgia treatment including medication management and Stanza as a care option.
Product overview
Swing Therapeutics is a digital therapeutics company offering a portfolio of products focused on chronic pain conditions, primarily fibromyalgia. The core product is Stanza, an FDA-cleared digital behavioral therapy delivering Acceptance and Commitment Therapy (ACT) via smartphone app. This is complemented by Swing Care, a virtual specialty clinic that provides comprehensive, multimodal fibromyalgia treatment incorporating Stanza as one care option alongside medication management and lifestyle support. The products work together to provide both standalone digital therapy access and integrated clinical care delivery.
Differentiator
Problem solved
Functional benefit
Brands
- Stanza: FDA-cleared digital behavioral therapy for treatment of fibromyalgia symptoms in adult patients. Delivers Acceptance and Commitment Therapy (ACT) through a smartphone application.
- Swing Care
Products and services
- Stanza Stanza is an FDA-cleared prescription digital behavioral therapy that delivers Acceptance and Commitment Therapy (ACT) through a smartphone application for the treatment of fibromyalgia symptoms in adult patients. The 12-week self-guided program includes 15-minute daily lessons, mindfulness activities, journaling, symptom tracking, and reminders, available on iOS and Android devices.
- Swing Care Swing Care is a virtual specialty clinic offering personalized, comprehensive fibromyalgia treatment that combines non-opioid pharmacological approaches with non-drug treatments including Stanza, medication management, lifestyle coaching, sleep management, and peer support. Services are available across multiple U.S. states including Illinois, Tennessee, Texas, Pennsylvania, Michigan, Missouri, Nevada, and Ohio.
Quantifiable outcome
- 73% of patients saw improvement in well-being (vs Control)
- +10 more outcomes
Companies that use Swing Therapeutics
Customer profileNamed customers6 records
Segments2 records
Ideal customer profiles3 records
Swing Therapeutics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Swing Therapeutics partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- University of ManitobacoreExclusive license of clinically validated online therapy program for digital delivery. The foundational program showed improvement in function and symptoms for people living with fibromyalgia through clinical trial.
- Highmark HealthcorePositive coverage decision for Stanza enabling commercial members in Pennsylvania, West Virginia, Delaware, and New York to access the treatment by prescription with insurance reimbursement.
- UPMCminorClinical partner in Pennsylvania offering Stanza as a treatment option for fibromyalgia patients.
- Southwest MedicalminorClinical partner in Nevada offering Stanza as a treatment option for fibromyalgia patients.
- Endless Frontier Labs (EFL)minorNYU Stern accelerator program that graduated Swing Therapeutics in its 2025-2026 cohort. EFL has facilitated $3.20 billion raised by 243 graduates.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
Swing Therapeutics competitors and assessment
Company assessmentDirect peers
- Pear Therapeutics: Former category-leading prescription digital therapeutics company (reSET, reSET-O, Somryst) that pioneered FDA-authorized PDTs and filed for bankruptcy in 2023. Most directly comparable to Swing in regulatory pathway, prescription distribution model, and therapeutic modality; the appointment of Pear's former CEO to Swing's board underscores the strategic similarity.
- Better Therapeutics: Prescription digital therapeutic company developing BT-001 for type 2 diabetes and other cardiometabolic conditions via behavioral intervention. Comparable as a venture-backed PDT company pursuing FDA authorization and payer reimbursement for chronic-condition DTx.
- Akili Interactive: FDA-authorized prescription digital therapeutic company (EndeavorRx for ADHD, EndeavorOTC) later acquired by Virtual Therapeutics. Closely comparable in PDT regulatory model, payer engagement, and consumer-facing digital therapy positioning.
- Click Therapeutics: Prescription digital therapeutics company with FDA-authorized products (e.g., CT-132 for migraine) and a pipeline spanning chronic conditions. Directly comparable as a venture-backed PDT peer pursuing FDA pathway and payer coverage.
- Big Health: Digital therapeutics company (Sleepio for insomnia, Daylight for anxiety) combining CBT-based digital therapy with payer and employer distribution. Comparable in CBT/behavioral digital therapy modality, chronic-condition focus, and payer-reimbursement strategy.
- Mahana Therapeutics: Digital therapeutics company developing FDA-authorized prescription DTx (previously Parallel, now Mahana IBS for irritable bowel syndrome). Comparable as a chronic-condition PDT pursuing regulatory and payer pathway in a specialty indication.
Broad incumbents
- Hinge Health: Large-scale digital MSK and chronic pain platform combining virtual PT, coaching, and wearable sensors; serves employers and payers. Comparable in chronic-pain digital care delivery, payer engagement, and value-based care positioning, though Hinge is significantly larger and more diversified.
- Omada Health: Established virtual chronic care platform (diabetes prevention, hypertension, MSK) with payer and employer distribution at scale. Comparable in digital chronic-condition care, payer reimbursement model, and emphasis on durable clinical outcomes.
- Headspace Health: Digital mental health and behavioral therapy company (Headspace, Ginger) offering CBT/mindfulness-based programs via app with employer and payer distribution. Comparable in behavioral therapy modality and payer/employer GTM, though broader scope than a single-condition DTx.
Emerging players
- Curable Health: Digital chronic pain management program using CBT and pain neuroscience education via app, with consumer and B2B distribution. Comparable as a chronic-pain digital therapy with behavioral (CBT) approach, though typically sold direct-to-consumer rather than as prescription DTx.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Swing Therapeutics social profiles
Digital presenceSwing Therapeutics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Swing Therapeutics leadership team
Management profileNumber of profiles
Profiles7 records
Swing Therapeutics funding detail
Funding detailFunding overview
Funding rounds4 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Swing Therapeutics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Swing Therapeutics
What does Swing Therapeutics do?
Swing Therapeutics develops and sells Stanza, an FDA-cleared prescription digital therapeutic that delivers Acceptance and Commitment Therapy (ACT) through a smartphone application for adult patients with fibromyalgia. The 12-week, 15-minute-per-day self-guided program includes lessons, mindfulness exercises, journaling, and symptom tracking, and is complemented by Swing Care, the company's own virtual specialty clinic offering comprehensive fibromyalgia treatment including medication management and Stanza as a care option.
Is Swing Therapeutics a public or private company?
Swing Therapeutics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Swing Therapeutics founded?
Swing Therapeutics was founded in 2019. It employs 11 to 50 people.
Where is Swing Therapeutics based?
Swing Therapeutics is headquartered in San Francisco, United States, in the North America region.
How does Swing Therapeutics make money?
Two revenue lines are on record. Prescription Digital Therapeutic Sales are the primary driver. The others are swing Care Virtual Clinic Services.
Who are Swing Therapeutics's main competitors?
Direct peers on record are Pear Therapeutics, Better Therapeutics, Akili Interactive, Click Therapeutics, Big Health and Mahana Therapeutics. Broad incumbents are Hinge Health, Omada Health and Headspace Health. Curable Health is listed as an emerging player.
Does Swing Therapeutics have an API?
No public API is recorded for Swing Therapeutics.
What industry is Swing Therapeutics in?
Swing Therapeutics's product category is Digital Therapeutics. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs). Its NAICS code is 621112 and its SIC code is 8000.